Ovarian cancer (OC) is one of the most common gynecological cancers, with the worst prognosis and the highest mortality rate. Peritoneal dissemination (or carcinomatosis) accompanied by ascites formation is the most unfavorable factor in the progression and recurrence of OC. Tumor cells in ascites are present as either separate cells or, more often, as cell aggregates, i.e., spheroids which promote implantation on the surface of nearby organs and, at later stages, metastases to distant organs. Malignant ascites comprises a unique tumor microenvironment; this fact may be of relevance in the search for new prognostic and predictive factors that would make it possible to personalize the treatment of patients with OC. However, the precise mecha...
AbstractAt least one third of all cases of epithelial ovarian cancer are associated with the product...
At least one third of all cases of epithelial ovarian cancer are associated with the production of a...
Malignant ascites is often found in ovarian cancer, moreover, about 10% of patients suffer from recu...
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastati...
Abstract Background Malignant ascites often develops in advanced stages of ovarian carcinoma, consis...
More than one third of ovarian cancer patients present with ascites at diagnosis, and almost all hav...
Epithelial ovarian cancer (EOC) has a relatively high mortality rate (~55%). One of the presiding ca...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Abstract Background Ovarian cancer is characterized by a wide-spread intra-abdominal metastases whic...
BACKGROUND: Ovarian cancer is characterized by a wide-spread intra-abdominal metastases which repres...
Background: Ovarian cancer is characterized by a wide-spread intra-abdominal metastases which repres...
Ovarian carcinoma kills hundreds of thousands of women annually. High grade serous carcinoma is the ...
Ascites refers to the abnormal accumulation of fluid in the peritoneum resulting from an underlying ...
Background. Peritoneal carcinomatosis (PC) is one of the most unfavorable factors of ovarian cancer ...
Das ovarialkarzinom ist durch eine erhöhte Aszitesbildung und durch aggressive Metastasierung im Per...
AbstractAt least one third of all cases of epithelial ovarian cancer are associated with the product...
At least one third of all cases of epithelial ovarian cancer are associated with the production of a...
Malignant ascites is often found in ovarian cancer, moreover, about 10% of patients suffer from recu...
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy and has a unique metastati...
Abstract Background Malignant ascites often develops in advanced stages of ovarian carcinoma, consis...
More than one third of ovarian cancer patients present with ascites at diagnosis, and almost all hav...
Epithelial ovarian cancer (EOC) has a relatively high mortality rate (~55%). One of the presiding ca...
<p>Most ovarian cancer patients at diagnosis (stage IIIc/IV) present with ascites (CN) which consist...
Abstract Background Ovarian cancer is characterized by a wide-spread intra-abdominal metastases whic...
BACKGROUND: Ovarian cancer is characterized by a wide-spread intra-abdominal metastases which repres...
Background: Ovarian cancer is characterized by a wide-spread intra-abdominal metastases which repres...
Ovarian carcinoma kills hundreds of thousands of women annually. High grade serous carcinoma is the ...
Ascites refers to the abnormal accumulation of fluid in the peritoneum resulting from an underlying ...
Background. Peritoneal carcinomatosis (PC) is one of the most unfavorable factors of ovarian cancer ...
Das ovarialkarzinom ist durch eine erhöhte Aszitesbildung und durch aggressive Metastasierung im Per...
AbstractAt least one third of all cases of epithelial ovarian cancer are associated with the product...
At least one third of all cases of epithelial ovarian cancer are associated with the production of a...
Malignant ascites is often found in ovarian cancer, moreover, about 10% of patients suffer from recu...